Thursday, May 19, 2011

5/20 RegenMD

     
    RegenMD    
   
Harvard Bioscience Ranked Massachusetts' #1 Biotech Company in Boston Globe 100
May 19, 2011 at 9:30 PM
 
This recognition is a consequence of our strong track record of growth and profitability of our core life science research tools business, even during the Great Recession, our exciting growth opportunity in regenerative medicine and the exceptional ...
See all stories on this topic »
   
   
A Nanotubes Patch to Help Heal the Heart
May 19, 2011 at 9:02 PM
 
Unlike other materials used in tissue engineering, the carbon nanotube patch would not naturally degrade in the body. "The idea would be that the heart tissue would grow around these carbon nanotubes and they would continue to provide electrical ...
See all stories on this topic »

MIT Technology Review
   
   
Predicting the fate of personalized cells next step toward new therapies
May 19, 2011 at 4:27 PM
 
To that end, Kenneth S. Zaret, PhD, professor of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, and associate director of the Penn Institute for Regenerative Medicine, and Cheng-Ran Xu, PhD, ...
See all stories on this topic »
   
   
Amnion-derived stem cells: in quest of clinical applications
May 19, 2011 at 7:14 AM
 
In the promising field of regenerative medicine, human perinatal stem cells are of great interest as potential stem cells with clinical applications. Perinatal stem cells could be isolated from normally discarded human placentae, which are an ideal ...
See all stories on this topic »
   
   
Stem-cell agency reaching out in Valley
May 19, 2011 at 3:53 AM
 
The California Institute for Regenerative Medicine is coming to town Saturday. The stem cell institute will host a free, five-hour program from 9 am to 2 pm Saturday at the Hilton Stockton. The event is titled "Inflammation: The Root of All Evil? ...
See all stories on this topic »
   
   
Shire makes $750m regenerative medicines acquisition
May 19, 2011 at 3:53 AM
 
Shire's ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. The UK specialty pharma company has long eyed a move into this area and said the deal with Advanced ...
See all stories on this topic »

InPharm
   
   
Cardiologist/Entrepreneur Eyed for Stem Cell Agency Chair
May 19, 2011 at 2:53 AM
 
Media Files
litvack+cedars.jpg (JPEG Image)
   
   
House Introduces Bill on Regenerative Medicine
May 19, 2011 at 1:58 AM
 
Brian P. Bilbray (R-CA) and Diana DeGette (D-CO), is called the Regenerative Medicine Promotion Act of 2011, and seeks to establish funding priorities for research and development of regenerative medicine products, and to develop a regulatory ...
See all stories on this topic »
   
     
 
This email was sent to regenmd@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: